Article
Early dynamic changes of quasispecies in the reverse transcriptase region of hepatitis B virus in telbivudine treatment.
Antiviral research - 1 Nov 2021
Tang Xia, Huang Wenxun, Kang Juan, Ding Keyue
Abstract excerpt
BACKGROUND: Telbivudine (LdT) - a synthetic thymidine β-L-nucleoside analogue (NA) - is an effective inhibitor for hepatitis B virus (HBV) replication. The quasispecies spectra in the reverse transcriptase (RT) region of the HBV genome and their dynamic changes associated with LdT treatment remains largely unknown. METHODS: We prospectively recruited a total of 21 treatment-naive patients with chronic HBV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
